Changjiang Pharmaceutical Group Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 0/6
Changjiang Pharmaceutical Group's earnings have been declining at an average annual rate of -8%, while the Auto Components industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 0.2% per year.
Wichtige Informationen
-8.0%
Wachstumsrate der Gewinne
-7.9%
EPS-Wachstumsrate
Auto Components Wachstum der Industrie | 3.8% |
Wachstumsrate der Einnahmen | 0.2% |
Eigenkapitalrendite | -115.3% |
Netto-Marge | -242.4% |
Letzte Ertragsaktualisierung | 30 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%
Sep 30Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 31%
Aug 11Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
Jun 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough
Apr 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%
Feb 27Aufschlüsselung der Einnahmen und Ausgaben
Wie Changjiang Pharmaceutical Group Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
---|---|---|---|---|
30 Sep 24 | 277 | -671 | 180 | 5 |
30 Jun 24 | 795 | -734 | 368 | 6 |
31 Mar 24 | 1,120 | -630 | 338 | 7 |
31 Dec 23 | 1,198 | -606 | 300 | 8 |
30 Sep 23 | 1,215 | -167 | 239 | 12 |
30 Jun 23 | 1,099 | -7 | 188 | 11 |
31 Mar 23 | 1,207 | -61 | 181 | 20 |
01 Jan 23 | 1,615 | -23 | 213 | 26 |
30 Sep 22 | 1,966 | -20 | 223 | 33 |
30 Jun 22 | 2,056 | -75 | 261 | 39 |
31 Mar 22 | 2,122 | 4 | 259 | 37 |
01 Jan 22 | 2,362 | 49 | 248 | 39 |
30 Sep 21 | 2,388 | 121 | 213 | 41 |
30 Jun 21 | 2,143 | 117 | 178 | 43 |
31 Mar 21 | 1,874 | 90 | 166 | 46 |
31 Dec 20 | 1,215 | 25 | 141 | 43 |
30 Sep 20 | 784 | -696 | 188 | 46 |
30 Jun 20 | 636 | -723 | 183 | 47 |
31 Mar 20 | 591 | -700 | 163 | 44 |
31 Dec 19 | 725 | -670 | 176 | 48 |
30 Sep 19 | 763 | 22 | 136 | 37 |
30 Jun 19 | 897 | 81 | 134 | 36 |
31 Mar 19 | 988 | 115 | 141 | 34 |
31 Dec 18 | 881 | 102 | 127 | 33 |
30 Sep 18 | 947 | 123 | 140 | 32 |
30 Jun 18 | 898 | 103 | 114 | 52 |
31 Mar 18 | 829 | 80 | 113 | 44 |
31 Dec 17 | 744 | 70 | 109 | 34 |
30 Sep 17 | 564 | 53 | 83 | 29 |
30 Jun 17 | 409 | 35 | 89 | 0 |
31 Mar 17 | 241 | 5 | 80 | 0 |
31 Dec 16 | 235 | 4 | 77 | 0 |
30 Sep 16 | 214 | 6 | 70 | 0 |
30 Jun 16 | 194 | -1 | 73 | 0 |
31 Mar 16 | 195 | 4 | 62 | 0 |
31 Dec 15 | 191 | 5 | 60 | 0 |
30 Sep 15 | 214 | 11 | 64 | 0 |
30 Jun 15 | 231 | 21 | 52 | 0 |
31 Mar 15 | 244 | 26 | 54 | 0 |
31 Dec 14 | 243 | 29 | 50 | 0 |
30 Sep 14 | 254 | 35 | 47 | 0 |
30 Jun 14 | 248 | 34 | 49 | 0 |
31 Mar 14 | 254 | 34 | 50 | 0 |
31 Dec 13 | 255 | 35 | 50 | 0 |
Qualität der Erträge: 300391 is currently unprofitable.
Wachsende Gewinnspanne: 300391 is currently unprofitable.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 300391 is unprofitable, and losses have increased over the past 5 years at a rate of 8% per year.
Beschleunigtes Wachstum: Unable to compare 300391's earnings growth over the past year to its 5-year average as it is currently unprofitable
Erträge im Vergleich zur Industrie: 300391 is unprofitable, making it difficult to compare its past year earnings growth to the Auto Components industry (10.1%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 300391 has a negative Return on Equity (-115.28%), as it is currently unprofitable.